• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtech regulatory news for the week of Mar. 17, 2014

Medtech regulatory news for the week of Mar. 17, 2014

March 18, 2014 By MassDevice staff

U.S. FDA considering new requirements for off-label use data

March 12, 2014 by MassDevice

YYYYALTTAG

By Stewart Eisenhart, Emergo Group

US regulators have published updated draft guidance on recommendations for distribution of scientific and marketing materials related to unapproved uses of medical devices, drugs and other products under Food and Drug Administration oversight. The agency is accepting public comments on the guidance through April 2014.

Revising guidelines originally issued in 2009, the FDA has now developed recommended best practices for manufacturers providing information to medical or scientific publications that discuss unapproved uses for devices already registered for sale in the US. Read more

Another warning letter for Hospira

March 12, 2014 by Arezu Sarvestani

Another warning letter for Hospira

Infusion technologies maker Hospira remains in the FDA’s cross-hairs after agency inspectors asked for more information about a North Carolina manufacturing facility that has been in hot water for years.

In the new warning, FDA officials cited at least 1 device malfunction in the field associated with injection systems that failed leak testing but were nonetheless allowed on shelves. One of the devices in the product lot was labeled “non-conforming” during October 2012 testing, but that failure was deemed unrepresentative of the batch and the devices were sent to market anyway, inspectors said. Read more

SafeOp Surgical lands FDA nod for neuromonitoring device

March 13, 2014 by Brad Perriello

SafeOp Surgical lands FDA nod for neuromonitoring device

SafeOp Surgical said it won 510(k) clearance from the FDA for its EPAD neuromonitoring device.

The Stamford, Conn.-based company develops technology used to detect peripheral nerve damage caused by nerve compression or stretching. Read more

Boston Scientific's Ingevity MRI-safe cardiac pacing leads win EU nod

March 14, 2014 by Brad Perriello

Boston Scientific's Ingevity MRI-safe cardiac pacing leads win EU nod

Boston Scientific said it won CE Mark approval in the European Union for its Ingevity pacemaker leads, designed to be safe during MRI scans.

The Natick, Mass.-based medical device company said it’s already launched the Ingevity leads in countries that recognize the CE Mark. Read more

S. Korea decides Samsung Galaxy S5 is not a medical device | MassDevice.com On Call

March 17, 2014 by Arezu Sarvestani

MassDevice.com On Call

MASSDEVICE ON CALL — South Korean healthcare regulators are looking to make some changes to their medical device classifications after ruling that a Samsung’s (LON:BC94) new Galaxy S5 smartphone is not a medical device, according to local reports.

The Galaxy S5 sparked review of the country’s regulations when it was revealed last month that the smartphone features a built-in heart-rate sensor. Read more

Filed Under: News Well, Regulatory/Compliance

More recent news

  • Data backs DermaSensor skin cancer detection device
  • GE HealthCare expands digital imaging portfolio with enhanced MIM Encore software
  • Accelus wins FDA clearance for MRI compatibility of FlareHawk spinal implants
  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy